MOLECULAR PARTNERS ADS/1 Capital Reinvestment Ratio
MOLECULAR PARTNERS ADS/1 capital reinvestment ratio. MOLECULAR PARTNERS ADS/1 (6ML0) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow (€118.57 Million) in capital expenditures (€1.42 Million). Check MOLECULAR PARTNERS ADS/1 total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of MOLECULAR PARTNERS ADS/1 (2022–2022)
Capital reinvestment ratio of MOLECULAR PARTNERS ADS/1 from 2022 to 2022. This chart tracks MOLECULAR PARTNERS ADS/1's Capital Reinvestment Ratio across 1 annual periods. Also explore MOLECULAR PARTNERS ADS/1 annual equity growth to track the company's year-over-year net asset growth rate.
MOLECULAR PARTNERS ADS/1 Capital Reinvestment Ratio by Year (2022–2022)
MOLECULAR PARTNERS ADS/1 capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see MOLECULAR PARTNERS ADS/1 operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | €118.57 Million | €1.42 Million | — |